Multiple Imputation Approaches for Missing Time-to-Event Outcomes with Informative Censoring: Practical Considerations from a Simulation Study Based on Real Data

Authors

DOI:

https://doi.org/10.54103/2282-0930/28145

Keywords:

missing data, multiple imputations, survival analysis, informative censoring

Abstract

Missing outcomes data represent a common threat to the validity and robustness of clinical trials with time-to-event outcomes. Recent extensions of multiple imputations (MI), namely controlled-MI, have been introduced as a viable approach for sensitivity analysis in the presence of informative censoring, yet they lack validation based on real data. In this study we used data from a randomized trial to generate realistic scenarios of censoring mechanisms and compare several imputation approaches for missing outcome data. Our results confirm the relevance of multiple imputations especially in studies with long follow-up and higher proportion of potentially informative censoring.

 

Downloads

Download data is not yet available.

References

Bell ML, Fiero M, Horton NJ, Hsu CH. Handling missing data in RCTs; a review of the top medical journals. BMC Med Res Methodol. 2014;14:118. DOI: https://doi.org/10.1186/1471-2288-14-118

The Prevention and Treatment of Missing Data in Clinical Trials. Washington (DC)2010.

Groenwold RH, Donders AR, Roes KC, Harrell FE, Jr., Moons KG. Dealing with missing outcome data in randomized trials and observational studies. Am J Epidemiol. 2012;175(3):210–7. DOI: https://doi.org/10.1093/aje/kwr302

Altman DG. Missing outcomes in randomized trials: addressing the dilemma. Open Med. 2009;3(2):e51–3.

Tan PT, Cro S, Van Vogt E, Szigeti M, Cornelius VR. A review of the use of controlled multiple imputation in randomised controlled trials with missing outcome data. BMC Med Res Methodol. 2021;21(1):72. DOI: https://doi.org/10.1186/s12874-021-01261-6

Jackson D, White IR, Seaman S, Evans H, Baisley K, Carpenter J. Relaxing the independent censoring assumption in the Cox proportional hazards model using multiple imputation. Stat Med. 2014;33(27):4681–94. DOI: https://doi.org/10.1002/sim.6274

Cro S, Morris TP, Kenward MG, Carpenter JR. Sensitivity analysis for clinical trials with missing continuous outcome data using controlled multiple imputation: A practical guide. Stat Med. 2020;39(21):2815–42. DOI: https://doi.org/10.1002/sim.8569

Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, et al. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2019;380(4):347–57 DOI: https://doi.org/10.1056/NEJMoa1812389

Downloads

Published

2025-03-14

How to Cite

1.
Bellavia A, Guo M, Murphy S. Multiple Imputation Approaches for Missing Time-to-Event Outcomes with Informative Censoring: Practical Considerations from a Simulation Study Based on Real Data. ebph [Internet]. 2025 [cited 2026 Feb. 24];20(1). Available from: https://riviste.unimi.it/index.php/ebph/article/view/28145

Issue

Section

Original articles

Funding data